Tolerability and pharmacokinetics of RG 7348 in volunteers and preliminary efficacy in patients with hepatitis C

Trial Profile

Tolerability and pharmacokinetics of RG 7348 in volunteers and preliminary efficacy in patients with hepatitis C

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Apr 2012

At a glance

  • Drugs RG 7348 (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 22 Apr 2012 Results presented at the 113th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
    • 22 Apr 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top